It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Functional amyloids are considered as common building block structures of the biofilm matrix in different bacteria. In previous work, we have shown that the staphylococcal surface protein Bap, a member of the Biofilm-Associated Proteins (BAP) family, is processed and the fragments containing the N-terminal region become aggregation-prone and self-assemble into amyloid-like structures. Here, we report that Esp, a Bap-orthologous protein produced by Enterococcus faecalis, displays a similar amyloidogenic behavior. We demonstrate that at acidic pH the N-terminal region of Esp forms aggregates with an amyloid-like conformation, as evidenced by biophysical analysis and the binding of protein aggregates to amyloid-indicative dyes. Expression of a chimeric protein, with its Esp N-terminal domain anchored to the cell wall through the R domain of clumping factor A, showed that the Esp N-terminal region is sufficient to confer multicellular behavior through the formation of an extracellular amyloid-like material. These results suggest that the mechanism of amyloid-like aggregation to build the biofilm matrix might be widespread among BAP-like proteins. This amyloid-based mechanism may not only have strong relevance for bacteria lifestyle but could also contribute to the amyloid burden to which the human physiology is potentially exposed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 CSIC-UPNA-Gobierno de Navarra, Instituto de Agrobiotecnología (IDAB), Navarra, Spain (GRID:grid.424222.0) (ISNI:0000 0001 2242 5374)
2 CSIC-UPNA-Gobierno de Navarra, Instituto de Agrobiotecnología (IDAB), Navarra, Spain (GRID:grid.424222.0) (ISNI:0000 0001 2242 5374); IDISNA, Navarrabiomed-Universidad Pública de Navarra-Departamento de Salud, Navarra, Spain (GRID:grid.424222.0)
3 IDISNA, Navarrabiomed-Universidad Pública de Navarra-Departamento de Salud, Navarra, Spain (GRID:grid.424222.0)
4 Universitat Autonoma de Barcelona, Institut de Biotecnologia i de Biomedicina and Departament de Bioquimica i Biologia Molecular, Bellaterra, Spain (GRID:grid.7080.f)
5 King’s College London, Centre for Host Microbiome Interactions, Dental institute, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
6 IDISNA, Navarrabiomed-Universidad Pública de Navarra-Departamento de Salud, Navarra, Spain (GRID:grid.13097.3c)